feed,title,long_url,short_url
FDA:MedWatch,Ukoniq (umbralisib): Drug Safety Communication - FDA Approval of Lymphoma Medicine is Withdrawn Due to Safety Concerns,http://www.fda.gov/safety/medical-product-safety-information/ukoniq-umbralisib-drug-safety-communication-fda-approval-lymphoma-medicine-withdrawn-due-safety,https://bit.ly/3PZVqjI
FDA:MedWatch,Walmart Inc. Issues Voluntary Nationwide Recall of Various Artri Ajo King Joint Supplements Due to Potential Hidden Drug Ingredients,http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/walmart-inc-issues-voluntary-nationwide-recall-various-artri-ajo-king-joint-supplements-due,https://bit.ly/3GHyBgr
